NCT03107624

Brief Summary

This study aimed to evaluate the incidence of preinfarction angina in AMI patients and test the hypothesis that different clinical presentations before AMI onset can affect coronary plaque morphologies in AMI patients .

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
305

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2016

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2016

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

March 22, 2017

Completed
20 days until next milestone

First Posted

Study publicly available on registry

April 11, 2017

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2017

Completed
Last Updated

December 2, 2019

Status Verified

May 1, 2018

Enrollment Period

1 year

First QC Date

March 22, 2017

Last Update Submit

November 27, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Difference in culprit lesion morphologies assessed by OCT according to the presence or absence of PIA

    Plaque rupture was defined by the presence of a cavity formation in the plaque with a discontinuity of the fibrous cap. TCFA was defined as a lipid-rich plaque with a thin fibrous cap thickness of ≤ 65 um.Thrombus was identified by OCT as an irregular mass ≧0.25 mm in diameter protruding into the vessel lumen or attached to the surface of the vessel wall.Culprit lesion features in patients with PIA show a lower incidence of plaque rupture and TCFA compared to those without PIA.

    baseline

Secondary Outcomes (1)

  • In-hospital outcomes after AMI.

    baseline

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

AMI patients

You may qualify if:

  • Men or non-pregnant women \>18 years of age and \< 85 years of age;
  • Patients undergo cardiac catheterization for AMI;
  • Patients able to provide written informed consent.

You may not qualify if:

  • Patients cant afford medical history;
  • Cardiac shock;
  • Severe left ventricular dysfunction;
  • Left main disease;
  • Hepatic or kidney dysfunction;
  • OCT was performed after predilation;
  • Poor OCT image or massive thrombus.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The 2nd Affiliated Hospital of Harbin Medical University

Harbin, Heilongjiang, China

Location

Study Officials

  • Bo Yu, MD,PhD

    The Second Affiliated Hospital of Harbin Medical University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director of Cardiology of The 2nd Affiliated Hospital of Harbin Medical University

Study Record Dates

First Submitted

March 22, 2017

First Posted

April 11, 2017

Study Start

June 1, 2016

Primary Completion

June 1, 2017

Study Completion

June 1, 2017

Last Updated

December 2, 2019

Record last verified: 2018-05

Data Sharing

IPD Sharing
Will not share

Locations